Dr. Shalin Kiran Kothari, MD

Dr. Kothari practices at Yale Medicine in New Haven, Connecticut.

Dr. Kothari's NPI, 1417391525, was assigned on April 19, 2013. Dr. Kothari graduated from B. J. Medical College Ahmedabad in 2011. Dr. Kothari holds Connecticut license 64220.

Dr. Kothari's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Kothari's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Kothari is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Kothari to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kothari practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kothari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kothari is licensed in Connecticut.

CMS data shows 409 Medicare services from Dr. Kothari across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $27,650 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Kothari in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kothari's median patient age at 73, with 41% women.

In 2024, Dr. Kothari wrote 209 Medicare Part D claims for 40 patients. 73% of them were for generic drugs. CMS names the drug for 145 of them, across 6 drugs with 11 or more claims each, at $636,923 in total drug cost. In 2023, CMS named 97 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Kothari for performance year 2024, reported as part of a group. Dr. Kothari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kothari as offering telehealth.

Dmand AI links 27 papers to Dr. Kothari, published from 2013 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Lymphoma, Mantle-Cell. Dr. Kothari has published most often in Blood Adv. Dr. Kothari's most frequent co-authors are Reem Md Karmali, MD, Pallawi Torka, MD and Paolo F. Caimi, MD.

Dmand AI links Dr. Kothari to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell and Leukemia, Lymphocytic, Chronic, B-Cell. Open Payments lists research payments to Dr. Kothari that name 1 trial.

CMS Open Payments shows 21 general payments to Dr. Kothari from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 84% of the total. ADC Therapeutics America, Inc. paid the most, $17,481. It also lists 1 research payment totaling $60 in 2023, naming 1 clinical trial.

Dr. Kothari graduated from B. J. Medical College Ahmedabad in 2011.